High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

A. Broyl; R. Kuiper; M. van Duin; B. van der Holt; L. el Jarari; U. Bertsch; S. Zweegman; A. Buijs; D. Hose; H.M. Lokhorst; H. Goldschmidt; x HOVON Dutch-Belgian Hematology-Oncology Group; P. Sonneveld

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

Translated title of the contribution: High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

A. Broyl
, R. Kuiper
, M. van Duin
, B. van der Holt
, L. el Jarari
, U. Bertsch
, S. Zweegman
, A. Buijs
, D. Hose
, H.M. Lokhorst
, H. Goldschmidt
, x HOVON Dutch-Belgian Hematology-Oncology Group
, P. Sonneveld

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
Original language	Undefined/Unknown
Pages (from-to)	624-627
Number of pages	4
Journal	Blood
Volume	121
Issue number	4
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed?term=23233657

Cite this

Broyl, A., Kuiper, R., van Duin, M., van der Holt, B., el Jarari, L., Bertsch, U., Zweegman, S., Buijs, A., Hose, D., Lokhorst, H. M., Goldschmidt, H., HOVON Dutch-Belgian Hematology-Oncology Group, X., & Sonneveld, P. (2013). High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance. Blood, 121(4), 624-627. http://www.ncbi.nlm.nih.gov/pubmed?term=23233657

@article{77cce52b5ea545daa6c67ebf157ba26b,

title = "High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance",

author = "A. Broyl and R. Kuiper and \{van Duin\}, M. and \{van der Holt\}, B. and \{el Jarari\}, L. and U. Bertsch and S. Zweegman and A. Buijs and D. Hose and H.M. Lokhorst and H. Goldschmidt and \{HOVON Dutch-Belgian Hematology-Oncology Group\}, x and P. Sonneveld",

year = "2013",

language = "Undefined/Unknown",

volume = "121",

pages = "624--627",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "4",

}

Broyl, A, Kuiper, R, van Duin, M, van der Holt, B, el Jarari, L, Bertsch, U, Zweegman, S, Buijs, A, Hose, D, Lokhorst, HM, Goldschmidt, H, HOVON Dutch-Belgian Hematology-Oncology Group, X & Sonneveld, P 2013, 'High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance', Blood, vol. 121, no. 4, pp. 624-627. <http://www.ncbi.nlm.nih.gov/pubmed?term=23233657>

TY - JOUR

T1 - High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

AU - Broyl, A.

AU - Kuiper, R.

AU - van Duin, M.

AU - van der Holt, B.

AU - el Jarari, L.

AU - Bertsch, U.

AU - Zweegman, S.

AU - Buijs, A.

AU - Hose, D.

AU - Lokhorst, H.M.

AU - Goldschmidt, H.

AU - HOVON Dutch-Belgian Hematology-Oncology Group, x

AU - Sonneveld, P.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0006-4971

VL - 121

SP - 624

EP - 627

JO - Blood

JF - Blood

IS - 4

ER -